Short answer: Willow sells compounded semaglutide for $299 a month all-in, and Hims sells FDA-approved GLP-1s from $298 a month all-in. For…
Ivim Health Review 2026: Real Cost, Medications and Safety
Compounded GLP-1s with weekly check-ins: about $150/month all-in for semaglutide ($74.99 fee + $75 medication). Checked Sept 22, 2026.
Quick verdict
Independent review of
Ivim Health ivimhealth.com
- Official prices checked September 22, 2026
- Compounded medication: not FDA-approved
- Best for
- People who want weekly monitoring at a low monthly cost
- Starting price
- $75/mo
- Key feature
- Weekly provider check-ins with dose adjustments
The closest monitoring of any low-cost compounded programme we review, at about $150 a month all-in.
Our rating
Pricing
Membership + compounded semaglutide
- Membership $74.99 + medication from $75
- Priced by plan length: 1, 2, 4 or 6 months
Membership + compounded tirzepatide
- Membership $74.99 + medication from $149
Membership only
- $74.99 a month
- Covers provider care, weekly check-ins, nutrition and tracking tools
Prices can change. Check the provider’s site for current pricing. Last checked September 22, 2026.
Pros and cons
Pros
- Among the lowest compounded medication prices we track, from $75 a month
- Weekly provider check-ins rather than monthly, with dose adjustments
- Several plan lengths, from one month to six
- Also covers hormone therapy and other services in one account
Cons
- Compounded medications are not FDA-approved
- A $74.99 monthly fee sits on top of every medication price
- Brand-name prices are not published
- Customer ratings not verified for this review
Features
Specifications
| Service type | Telehealth weight management with weekly provider check-ins |
|---|---|
| Medications | Compounded semaglutide and tirzepatide; brand-name drugs where a provider prescribes them, with prices not published |
| Programme fee | $74.99 a month, required for all patients |
| Medication pricing | Compounded semaglutide from $75 a month, tirzepatide from $149 a month |
| Plan lengths | 1, 2, 4 or 6 months, chosen at checkout |
| Monitoring | Weekly check-ins in the app with dose adjustments by a licensed provider |
| Company | Founded 2021; Ivim says it works with more than 90 providers |
| Other services | Hormone therapy from $199.99 a month including the membership, plus NAD+, lipotropic injections and supplements |
| Trustpilot | Not verified for this review |
| Data status | Prices reported from ivimhealth.com in 2026; confirm the plan length and total at checkout |
Full review
- Our score
- 6.5/10
- All-in from
- $150/mo
- Medication type
- Compounded (not FDA-approved)
- Membership
- $74.99/mo
Ivim Health at a glance
Ivim Health charges a $74.99 monthly programme fee plus medication. With compounded semaglutide from $75 a month, that is about $150 all-in, or roughly $224 with tirzepatide. What sets it apart is weekly provider check-ins rather than monthly ones. Prices checked September 22, 2026.
What Ivim Health offers
The weight programme prescribes compounded semaglutide and tirzepatide. Ivim also treats hormone health, and sells NAD+ and lipotropic injections and supplements, so one account can cover several services. Hormone therapy is $199.99 a month including the membership. Brand-name GLP-1 prices are not published.
How Ivim Health works
You choose a plan length at checkout, either one, two, four or six months, and complete an online intake. A licensed provider reviews it and prescribes if appropriate. You then check in weekly through the app, and your provider adjusts the dose based on your progress and how well you tolerate it. Ivim says it works with more than 90 providers.
What Ivim Health costs
The programme fee is $74.99 a month and is required for everyone. Compounded semaglutide starts at $75 a month and tirzepatide at $149, so most members pay about $150 to $224 a month in total. Longer plans lower the medication price, so the plan length you pick at checkout decides your real cost.
Is Ivim Health legit and safe?
Ivim Health has operated since 2021 with a large provider network. Its compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness or manufacturing quality. The FDA has also warned that some compounded products contain salt forms such as semaglutide sodium, which are not the same active ingredient as the approved medicines, so ask which formulation you would receive. We did not verify a Trustpilot rating for this review.
Who Ivim Health is best for
Ivim suits people who want close monitoring: weekly check-ins and dose adjustments cost far less here than in most coaching-heavy programmes. Look elsewhere if you want FDA-approved medication, insurance billing, or a single price with no separate membership fee.
Our verdict
Ivim Health offers the closest monitoring of any low-cost compounded programme we review, at about $150 a month all-in. The trade-offs are compounded medication that is not FDA-approved and a membership fee on top of every price. This review is based on research of Ivim’s public pages and independent sources on September 22, 2026, not hands-on testing, and follows our methodology. TirzaSema has no affiliate relationship with Ivim Health.
How it compares
Short answer: both mainly sell compounded GLP-1s, which are not FDA-approved. Mochi Health is cheaper at low doses, from $139 a month…
N
Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a…
Alternatives
Ro Body pairs FDA-approved brand-name GLP-1s at manufacturer-matched prices with a separate membership. All-in cost is $298 to $598 a month month-to-month, or from…
FDA-approved GLP-1s through Amazon Pharmacy: pills from $149/month cash ($25 with insurance), injections from $299. Visit fees extra. Checked Sept 21, 2026.
Mochi Health offers the lowest all-in GLP-1 prices we have checked ($139 to $278 a month) with board-certified providers and dietitians. The trade-off: its…
Frequently asked questions
About $150 a month all-in for compounded semaglutide: a $74.99 programme fee plus medication from $75. Tirzepatide works out to about $224. Checked September 22, 2026.
Yes. The $74.99 monthly fee is required for every patient and is charged separately from the medication.
No. Its weight programme uses compounded semaglutide and tirzepatide, which are not FDA-approved.
Ivim uses weekly check-ins through its app, with providers adjusting your dose based on progress and tolerance.
Sources
- Ivim Health weight loss programme Ivim Health · checked September 22, 2026
- Ivim Health GLP-1 weight loss program pricing Santelog / Nasdaq wire · checked September 22, 2026
- Ivim Health reviews ConsumerAffairs · checked September 22, 2026
User reviews
No user reviews yet.
How we test
TirzaSema GLP-1 Provider Scoring Methodology
This methodology explains how TirzaSema scores GLP-1 telehealth providers and programs. Scores are a weighted average of five categories, and every review shows the full breakdown. Affiliate relationships and commission rates are not part of the methodology.
- Features · 25%
- Performance · 25%
- Ease of use · 15%
- Value for money · 20%
- Customer support · 15%
Prices are collected from each provider's public pricing pages and, where possible, confirmed during sign-up. Medication and membership costs are recorded separately, prices are shown by dose where published, introductory offers are labeled, and every price carries the date it was checked. When a review is based on hands-on testing we describe exactly what we did; when it is based on public information only, we say so.
FDA-approved medications themselves are not scored. They are listed as reference entries with their FDA-labeled uses and official manufacturer prices.
Some links on TirzaSema are affiliate links. Commissions never affect scores, rankings, pros and cons, or medical and regulatory information. See our Affiliate Disclosure.
Final verdict
The closest monitoring of any low-cost compounded programme we review, at about $150 a month all-in.
Ivim Health Weight Management
$75/mo
TirzaSema Editorial Team
Research and editorial team
The TirzaSema Editorial Team researches U.S. GLP-1 prices and telehealth programs using official manufacturer, FDA and provider sources. Every review states whether it is based on hands-on testing or on research of public information,…
